Reliance on Self-Medication Increase Delays in Diagnosis and Management of GI Cancers: Results From Nepal

Abstract

PURPOSE Patients with GI cancers in Nepal often present with advanced disease and poor outcomes. The purpose of the study was to determine the time to presentation, diagnosis, and treatment of GI cancer and the baseline factors that may be associated with delays. PATIENTS AND METHODS An institutional review board–approved study was performed in Kathmandu, Nepal, from July 2018 to June 2019. Patients with newly diagnosed GI cancers were asked to fill out a standardized questionnaire. Baseline factors such as residence, literacy, and use of self-medication were recorded. Patients were asked to report the time from first symptom to presentation, time from primary care visit to pathologic diagnosis, and time from diagnosis to surgery and/or treatment. Baseline factors were analyzed using 2-tailed t tests (Prism 8.0; GraphPad, La Jolla, CA) to determine whether any factors were associated with longer time delays in these 3 intervals. RESULTS The cohort comprised of 104 patients with a median age of 53.5 years (range, 22-77 years); 61.5% were men, 46.2% had upper GI cancers, and 83.7% presented with stage III or IV disease. The median time to presentation was 150 days, time to diagnosis was 220 days, and time to treatment was 50 days. There was no statistically significant difference in time intervals between upper and lower GI cancers. Use of self-medication (88.5%) was the only factor associated with longer time intervals to presentation, diagnosis, and treatment. CONCLUSION Patients in Nepal have long time intervals to presentation, diagnosis, and treatment of GI cancer. Self-medication led to longer delays. Reasons for self-medication and other potential barriers will be explored in future studies in the hopes of improving outcomes.

Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study

“…Herbal medicines are frequently used by cancer patients, ranging in prevalence from 19.7% to 69% [ 37 , 38 , 39 , 40 ], and patients taking herbal medicines have lower overall survival at 3 and 5 years than patients not taking herbal medicines [ 37 ], which underlines the unknown safety of these behaviors and self-medication practices. Moreover, self-medication practices can delay cancer diagnosis (e.g., gastrointestinal cancer [ 41 , 42 ], hematological malignancies [ 43 ]).…”

The SYMPTOM‐upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help‐seeking in Australian upper gastrointestinal cancer patients

“…Furthermore, they also found that despite abdominal pain being the most common help‐seeking trigger, help‐seeking was often delayed due to its attribution to ‘normal’ indigestion (Humphrys et al, 2020; Mills et al, 2017). An Italian and Nepalese study reported self‐medication to treat indigestion, which was associated with longer time to presentation, diagnosis and treatment (Dulal et al, 2020; Gobbi et al, 2013). In our study, however, patients tried alleviating their symptoms by changing their diet rather than taking medication.…”

Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve Status Quo

“…However, like other developing countries, out-of-pocket (OOP) expenditure is the dominant source of health financing in Nepal and Nigeria. More than 11% of Nepalese spend 10% of their total expenses for health [ 38 ], where 1.67% of the population is pushed below the poverty line of PPP$ 1.90 per capita per day [ 39 ]. Generally, 70% of the Nepalese use OOP payment for their health care [ 40 ]; however patients with cancer are beginning to receive help as the Nepalese government is currently providing financial assistance of up to NRs 100,000 (Euro 735.41, USD 830.17 exchange rate as of June 9, 2020) per person for cancer treatment under a scheme to support impoverished citizens [ 41 ].…”